The AstraZeneca Global Hub in Barcelona is one of Europe’s largest and most significant centers for biomedical research and digital innovation. Launched in 2023, it serves as a central point for accelerating the development of next-generation treatments across the company’s main therapeutic areas. 

Core Mission & Operations

• Biomedical Innovation: The hub focuses on developing new molecules and therapies using a model that combines traditional science with Data Science, Artificial Intelligence (AI), and precision medicine.
• Therapeutic Areas: Research projects target six key fields: Oncology, Cardiovascular, Renal and Metabolism, Respiratory and Immunology, Vaccines and Immunotherapies, and Rare Diseases (supported by its subsidiary Alexion).
• Clinical Excellence: The center drives over 380 research projects and 190 clinical trials. 

Strategic Investment & Workforce

• Massive Investment: AstraZeneca has committed €1.3 billion to the hub through 2027.
• Growing Talent: The hub currently employs approximately 1,600 professionals from 62 nationalities, with plans to reach 2,000 employees by late 2025.
• Language: As a global innovation center, English is the primary working language.